Aspen Clinical Research is currently taking part in a clinical research study of an investigational medication for adults ages 60 through 85 who are experiencing memory loss due to mild Alzheimer’s Disease.
The purpose of this study is to determine the effective dose of the investigational medication based on results found in patients with mild dementia.
The potential sleep enhancing capacities of the investigational medication may also be important to this study. Recent clinical and biochemical evidence has identified an interesting link between sleep, cognitive dysfunction and Alzheimer’s disease.
The participant’s initial visit to the research clinic will be a screening visit. During this visit he/she will meet with a study coordinator to fully review study details. If he/she decide to participate, a more in depth assessment of the participant’s health will take place to determine final eligibility. If he/she is eligible and chooses to enroll, the participant will be required to return to our research clinic at various times for treatment and follow-up visits.
Space in the study is. limited. Health insurance is not required. All clinical visits, medications, and physical exams are provided to you at no cost. You may be compensated for the time and travel involved for this study.
For more in-depth information regarding this study please click HERE.
Please complete the form below to see if you pre-qualify for the study. All information you provide to Aspen Clinical Research will remain strictly confidential.
Disclaimer: Not all individuals that complete the on-line questionnaire will qualify for the study. An in-depth study and medical evaluation must be completed in person in order to qualify for the study.